(Date:5/16/2008)...ion of a Small Molecule with Dem...., May 16 /- Nektar,Therape...oday from a Phase 1,study of NKTR- 102, PEGylated ...activity in patients with refractory solid tumors....olecule PEGylation technology,produced an increase...
(Date:5/16/2008)...ant Reductions in Selected ...in 2008 Proceedings of the American Society of ...GO, May 16 /- ADVENTRX Phar...at, in a registrational bioequivalence,clinical st...ant reduction,in general disorders and administrat...
(Date:5/15/2008).../ -- Medivation, Inc.,(Nasdaq: MDVN ) today annou...trial of its novel androgen receptor antagonist, M...at the 44th American Society of Clinical Oncology,...e: New Targeted Strategies for Patients with Prost...at 11:30 a.m. Central Time Abstract title: "Phase...
(Date:5/15/2008)...rstCall/ -- Cytopia Limited,(ASX: CYT) today annou...ntation on CYT997 at the 2008 Annual Meeting of th...l be accessible to the public via ASCO,s,website ... (US EDT)., The oral presentation, entitled "Phas...scular disrupting agent, in patients with advanced...
Breaking Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Cleveland Clinic Press Releases Book About a Surgeons Mission to Perform the Worlds First Full Face Transplant 11690 1Cleveland Clinic Press Releases Book About a Surgeons Mission to Perform the Worlds First Full Face Transplant 11690 2Neuromusic showtime 11688 1Neuromusic showtime 11688 2Neuromusic showtime 11688 3USHEALTH Group Announces Appointment of Executive Vice President 11684 1USHEALTH Group Announces Appointment of Executive Vice President 11684 2BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 1BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 2BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 3BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 4BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 5BioElectronics Corporation 28BIEL 29 SqueezeTrigger Price is 240 11 11680 6...ire-FirstCall/ -- Micromet,Inc. , a biopharmaceut... proprietary antibody-based products for cancer, i...t a study published recently,in the Proceedings of... findings of several other studies that EpCAM (CD3...oduct candidates adecatumumab,(MT201) and MT110, m...
...bulin Study Uncovers Sample,Manipulation, Design F...ire/ -- An analysis,released today critically exam...a link between autism and Rh immune globulin,(RhIg...based,preservative thimerosal. Besides extensive d...f the study sample, so that,earlier data revealing...
Other Medicine Technology:Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 2Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 3Publication Confirms that EpCAM, the Target for Two of Micromet's,Product Candidates, Is Overexpressed on Cancer Stem Cells of,Certain Cancers 4Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3(Date:5/16/2008)...rican Society of Clinical Oncology meeting in Chic...e in about 25 percent of patients with colon cance... colorectal cancers will be staged. , This new... population-based statistic registries from 1992 t...hat outcomes of patients with positive nodes (Stag...
(Date:5/16/2008)...are medicine is in a precipitous decline, David C.... of Physicians (ACP), today joined with leading r... a call for comprehensive reforms to attract, recr...y care physicians. , During a panel discussion ... Dr. Dale and other panelists spoke about the chal...
(Date:5/16/2008)...il Seniors and People With,Disabilities, OAKLAND,...ds of,homecare workers across the state are outrag...o hours of service, wages and benefits,which woul...rs and the,people they serve deeper into poverty. ...ors and people with disabilities from Schwarzenegg...
(Date:5/16/2008)...with 10,000 Sensual O Condom Packs Donation Marks...ser, LOS ANGELES, May 16 /PRNewswire/ -- On Satur...n known best for his hit song "Everybody in the Cl...alth Institute (UHI) with,10,000 Sensual O Vibrati...s,being made to promote the launch of the Associat...
Breaking Medicine News(10 mins):Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Everybody in the Club Scream O! 2...nd compelling evidence of a genetic link to hypera... prevalent in fidgety youngsters. A research tea...rsity of Duisburg-Essen in western Germany studied...on-deficit hyperactivity disorder syndrome. <b...
...y at a three-day summit in Johannesburg, South Afr...ow-cost generic versions of drugs -- including tre...on the continent. Many African countries current... India and China, but both countries are subject t...
...e has evolved to become resistant to all classes o...ionals. // Accordingly, the U.S. Centers for Disea...ill no longer recommend the use of fluoroquinolone...t strains in recent years that subdue them. <...
...nstitute of Mental Health, not only is the rates o...eps // being taken to ensure that suicide attempts...he next three years. At the same time there are ...atients registered with them, who are not complian...
Other Medicine News:A general purpose instrument for use around the femur and acetabulum.
Standard locking pliers.
Delicate side cutting wire cutter with carbide inserts.
The double action wire cutter has both side and end cutting capabilities.
Medicine Products: